483 related articles for article (PubMed ID: 14724445)
1. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients.
Dragieva G; Hafner J; Dummer R; Schmid-Grendelmeier P; Roos M; Prinz BM; Burg G; Binswanger U; Kempf W
Transplantation; 2004 Jan; 77(1):115-21. PubMed ID: 14724445
[TBL] [Abstract][Full Text] [Related]
2. Fractionated illumination improves the outcome in the treatment of precancerous lesions with photodynamic therapy.
Puizina-Ivić N; Zorc H; Vanjaka-Rogosić L; Mirić L; Persin A
Coll Antropol; 2008 Oct; 32 Suppl 2():67-73. PubMed ID: 19138010
[TBL] [Abstract][Full Text] [Related]
3. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
[TBL] [Abstract][Full Text] [Related]
4. [Topical photodynamic therapy in basal and squamous cell carcinoma and penile Bowen's disease with 20% aminolevulinic acid, and exposure to red light and infrared light].
Harth Y; Hirshovitz B
Harefuah; 1998 Apr; 134(8):602-5, 672, 671. PubMed ID: 10911421
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of photodynamic therapy with topical 5-aminolevulinic acid using intense pulsed light for Bowen's disease.
Hasegawa T; Suga Y; Mizuno Y; Haruna K; Ogawa H; Ikeda S
J Dermatol; 2010 Jul; 37(7):623-8. PubMed ID: 20629828
[TBL] [Abstract][Full Text] [Related]
6. Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma.
Calzavara-Pinton PG; Venturini M; Sala R; Capezzera R; Parrinello G; Specchia C; Zane C
Br J Dermatol; 2008 Jul; 159(1):137-44. PubMed ID: 18489606
[TBL] [Abstract][Full Text] [Related]
7. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis.
Moloney FJ; Collins P
Br J Dermatol; 2007 Jul; 157(1):87-91. PubMed ID: 17501954
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the use of the pulsed dye laser in the treatment of Bowen's disease using 5-aminolaevulinic acid phototherapy.
Britton JE; Goulden V; Stables G; Stringer M; Sheehan-Dare R
Br J Dermatol; 2005 Oct; 153(4):780-4. PubMed ID: 16181460
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma.
Dijkstra AT; Majoie IM; van Dongen JW; van Weelden H; van Vloten WA
J Eur Acad Dermatol Venereol; 2001 Nov; 15(6):550-4. PubMed ID: 11843215
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials.
Piacquadio DJ; Chen DM; Farber HF; Fowler JF; Glazer SD; Goodman JJ; Hruza LL; Jeffes EW; Ling MR; Phillips TJ; Rallis TM; Scher RK; Taylor CR; Weinstein GD
Arch Dermatol; 2004 Jan; 140(1):41-6. PubMed ID: 14732659
[TBL] [Abstract][Full Text] [Related]
12. Split-face-study using two different light sources for topical PDT of actinic keratoses:non-inferiority of the LED system.
Babilas P; Travnik R; Werner A; Landthaler M; Szeimies RM
J Dtsch Dermatol Ges; 2008 Jan; 6(1):25-32. PubMed ID: 17995967
[TBL] [Abstract][Full Text] [Related]
13. Topical photodynamic therapy of actinic keratosis in renal transplant recipients.
Piaserico S; Belloni Fortina A; Rigotti P; Rossi B; Baldan N; Alaibac M; Marchini F
Transplant Proc; 2007; 39(6):1847-50. PubMed ID: 17692630
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo comparison of two different light sources for topical photodynamic therapy.
Babilas P; Kohl E; Maisch T; Bäcker H; Gross B; Branzan AL; Bäumler W; Landthaler M; Karrer S; Szeimies RM
Br J Dermatol; 2006 Apr; 154(4):712-8. PubMed ID: 16536815
[TBL] [Abstract][Full Text] [Related]
15. Huge Bowen's disease: a pitfall of topical photodynamic therapy.
Park JY; Kim SK; Cho KH; Kim YC
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):546-8. PubMed ID: 24284109
[TBL] [Abstract][Full Text] [Related]
16. Large patches of Bowen's disease treated by topical aminolaevulinic acid photodynamic therapy.
Stables GI; Stringer MR; Robinson DJ; Ash DV
Br J Dermatol; 1997 Jun; 136(6):957-60. PubMed ID: 9217836
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the efficacy of ALA-PDT using an excimer-dye laser (630 nm) and a metal-halide lamp (600 to 740 nm) for treatment of Bowen's disease.
Mizutani K; Akita Y; Yanagishita T; Kimura M; Tanaka T; Kinoshita Y; Nakano A; Tamada Y; Matsumoto Y; Watanabe D
Photodermatol Photoimmunol Photomed; 2012 Jun; 28(3):142-6. PubMed ID: 22548396
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of 3 different light doses in the treatment of actinic keratosis with 5-aminolevulinic acid photodynamic therapy: a randomized, observer-blinded, intrapatient, comparison study.
Radakovic-Fijan S; Blecha-Thalhammer U; Kittler H; Hönigsmann H; Tanew A
J Am Acad Dermatol; 2005 Nov; 53(5):823-7. PubMed ID: 16243131
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy in combination with CO2 laser for the treatment of Bowen's disease.
Cai H; Wang YX; Zheng JC; Sun P; Yang ZY; Li YL; Liu XY; Li Q; Liu W
Lasers Med Sci; 2015 Jul; 30(5):1505-10. PubMed ID: 25899562
[TBL] [Abstract][Full Text] [Related]
20. Methyl aminolevulinate: actinic keratoses and Bowen's disease.
Morton CA
Dermatol Clin; 2007 Jan; 25(1):81-7. PubMed ID: 17126745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
